{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:01:38Z","timestamp":1790276498205,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13000-016-0477-3","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T19:49:20Z","timestamp":1457466560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant"],"prefix":"10.1186","volume":"11","author":[{"given":"Eisuke","family":"Shiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuji","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hisaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"477_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","volume":"1","author":"DJ Evans","year":"1972","unstructured":"Evans DJ, Azzopardi JG. Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet. 1972;1:353\u20134.","journal-title":"Lancet"},{"key":"477_CR2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"N Weidner","year":"1987","unstructured":"Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59:1442\u201354.","journal-title":"Cancer"},{"key":"477_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1\u201330.","journal-title":"Am J Surg Pathol"},{"key":"477_CR4","first-page":"211","volume-title":"WHO classification of tumours of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC; 2013. p. 211\u20132.","edition":"4"},{"key":"477_CR5","first-page":"1018","volume-title":"Enzinger and Weiss\u2019s soft tissue tumors","author":"JR Goldblum","year":"2014","unstructured":"Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss\u2019s soft tissue tumors. 6th ed. Philadelphia: Mosby Elsevier; 2014. p. 1018\u201323.","edition":"6"},{"key":"477_CR6","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001;98:6500\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","volume":"284","author":"AE Bowe","year":"2001","unstructured":"Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun. 2001;284:977\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"477_CR8","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, et al. 1\u03b1,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1036\u201342.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"477_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00041552-200209000-00011","volume":"11","author":"R Kumar","year":"2002","unstructured":"Kumar R. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia. Curr Opin Nephrol Hypertens. 2002;11:547\u201353.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"477_CR10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","volume":"112","author":"T Berndt","year":"2003","unstructured":"Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest. 2003;112:785\u201394.","journal-title":"J Clin Invest"},{"key":"477_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00774-011-0290-8","volume":"30","author":"Y Imanishi","year":"2012","unstructured":"Imanishi Y, Hashimoto J, Ando W, Kobayashi K, Ueda T, Nagata Y, et al. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab. 2012;30:93\u20139.","journal-title":"J Bone Miner Metab"},{"key":"477_CR12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","volume":"33","author":"A Bahrami","year":"2009","unstructured":"Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol. 2009;33:1348\u201354.","journal-title":"Am J Surg Pathol"},{"key":"477_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jclinpath-2012-200852","volume":"65","author":"R Graham","year":"2012","unstructured":"Graham R, Krishnamurthy S, Oliveira A, Inwards C, Folpe AL. Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas. J Clin Pathol. 2012;65:907\u20139.","journal-title":"J Clin Pathol"},{"key":"477_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","volume":"39","author":"JM Carter","year":"2015","unstructured":"Carter JM, Caron BL, Dogan A, Folpe AL. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol. 2015;39:75\u201383.","journal-title":"Am J Surg Pathol"},{"key":"477_CR15","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","volume":"88","author":"AE Nelson","year":"2003","unstructured":"Nelson AE, Bligh RC, Mirams M, Gill A, Au A, Clarkson A, et al. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab. 2003;88:4088\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"477_CR16","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44:2711\u20138.","journal-title":"Hum Pathol"},{"key":"477_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","volume":"30","author":"A Ogose","year":"2001","unstructured":"Ogose A, Hotta T, Emura I, Hatano H, Inoue Y, Umezu H, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol. 2001;30:99\u2013103.","journal-title":"Skeletal Radiol"},{"key":"477_CR18","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/lary.21843","volume":"121","author":"D Sidell","year":"2011","unstructured":"Sidell D, Lai C, Bhuta S, Barnes L, Chhetri DK. Malignant phosphaturic mesenchymal tumor of the larynx. Laryngoscope. 2011;121:1860\u20133.","journal-title":"Laryngoscope"},{"key":"477_CR19","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","volume":"44","author":"K Uchihashi","year":"2013","unstructured":"Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, et al. Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis. Hum Pathol. 2013;44:2614\u20138.","journal-title":"Hum Pathol"},{"key":"477_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ol.2014.2081","volume":"8","author":"T Morimoto","year":"2014","unstructured":"Morimoto T, Takenaka S, Hashimoto N, Araki N, Myoui A, Yoshikawa H. Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases. Oncol Lett. 2014;8:67\u201371.","journal-title":"Oncol Lett"},{"key":"477_CR21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sder.2011.02.001","volume":"30","author":"TS Wang","year":"2011","unstructured":"Wang TS, Byrne PJ, Jacobs LK, Taube JM. Merkel cell carcinoma: update and review. Semin Cutan Med Surg. 2011;30:48\u201356.","journal-title":"Semin Cutan Med Surg"},{"key":"477_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.MP.0000056630.76035.F3","volume":"16","author":"PJ Zhang","year":"2003","unstructured":"Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol. 2003;16:229\u201335.","journal-title":"Mod Pathol"},{"key":"477_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.55.3.162","volume":"55","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Ascani S, Lenoncini L, Sabattini E, Zinzani PL, Piccaluga PP, et al. Hodgkin\u2019s lymphoma: the pathologist\u2019s viewpoint. J Clin Pathol. 2002;55:162\u201376.","journal-title":"J Clin Pathol"},{"key":"477_CR24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00256-011-1159-6","volume":"40","author":"P Suryawanshi","year":"2011","unstructured":"Suryawanshi P, Agarwal M, Dhake R, Desai S, Rekhi B, Reddy KB, et al. Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance. Skeletal Radiol. .2011;40:1481\u20135.","journal-title":"Skeletal Radiol"},{"key":"477_CR25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/PAS.0b013e31806772ec","volume":"31","author":"AC Baker","year":"2007","unstructured":"Baker AC, Rezeanu L, O\u2019Laughlin S, Unni K, Klein MJ, Siegal GP. Juxtacortical chondromyxoid fibroma of bone: a unique variant: a case study of 20 patients. Am J Surg Pathol. 2007;31:1662\u20138.","journal-title":"Am J Surg Pathol"},{"key":"477_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","volume":"235","author":"JC Lee","year":"2015","unstructured":"Lee JC, Jeng YM, Su SY, Wu CT, Tsai KS, Lee CH, et al. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 2015;235:539\u201345.","journal-title":"J Pathol"},{"key":"477_CR27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng.2927","volume":"46","author":"KH Nord","year":"2014","unstructured":"Nord KH, Lilljebj\u00f6rn H, Vezzi F, Nilsson J, Magnusson L, Tayebwa J, et al. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma. Nat Genet. 2014;46:474\u20137.","journal-title":"Nat Genet"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-016-0477-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T06:13:19Z","timestamp":1567663999000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.diagnosticpathology.org\/content\/11\/1\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s13000-016-0477-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"article-number":"26"}}